We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Justices Mull Drug Disclosures In Matrixx Fraud Case

Law360 (January 10, 2011, 8:10 PM EST) -- The U.S. Supreme Court on Monday weighed the implications of companies disclosing rare or dubious claims of drug side effects to shareholders, battering attorneys for the plaintiffs and Matrixx Initiatives Inc. with hypotheticals involving psychics, Satan and “nutty-nutty” consumers.

The case, Matrixx Initiatives et al. v. Siracusano et al., raises the question of whether drug companies must reveal adverse event reports that do not show statistically significant evidence that a problem reported by patients is specifically caused by the use of the particular drug.

In the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.